BioCryst Pharmaceuticals, Inc. (BCRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 1.64B |
| Enterprise Value | 1.99B |
| P/E Ratio | -5.67 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 2.05 |
| Price/Book Ratio | -4.92 |
| Enterprise/Revenue | 2.81 |
| Enterprise/EBITDA | -9.47 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -0.37 |
| Operating Margin | -0.3 |
| Return On Assets | -0.61 |
| Return On Equity | 0.94 |
| Revenue | 874.84M |
| Revenue/Share | 3.76 |
| Gross Profit | 855.76M |
| EBITDA | 347.65M |
| Net Income | 263.86M |
| Diluted EPS | 1.21 |
| Total Cash | 375M |
| Total Cash/Share | 1.47 |
| Total Debt | 828.2M |
| Total Debt/Equity | -2.08 |
| Current Ratio | 2.71 |
| Book Value Per Share | -1.55 |
| 52-Week Change | 5.81 |
| 52-Week High | 11.22 |
| 52-Week Low | 6.23 |
| Moving Average 50 Days | 8.38 |
| Moving Average 200 Days | 8.79 |
| Average Volume | 4.93M |
| Shares Outstanding | 257.3M |
| % Held by Institutions | 108.95 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |